Abstract
The permeability of the vasculature is a property of the capillary wall to obstruct movement of fluid or solutes driven by physiological force. The vasculature is essential for the health of normal tissues, hemostasis, lipid transport, and immune surveillance and is also an influential characteristic of many diseases in which it is greatly increased. The control mechanism of vascular permeability is a complex process that needs to be tightly regulated in order to preserve not only the vascular homeostasis but also its integrity. Here, transcellular and paracellular pathways play an important role as well as direct and indirect influence of the vascular permeability by molecules or blood pressure. In pathologies the vasculature is often affected by the disease process. This may result in neoangiogenesis, where an excessive formation of new, unstable, and hyperpermeable vessels with poor blood flow takes place. In this scenario the vascular endothelial growth factor (VEGF) plays a key role.
This is a preview of subscription content, log in via an institution to check access.
References
Abell RG (1946) The permeability of blood capillary sprouts and newly formed blood capillaries as compared to that of older capillaries. Am J Phys 147:237–745. https://doi.org/10.1152/ajplegacy.1946.147.2.237
Baluk P, Hirata A, Thurston G et al (1997) Endothelial gaps: time course of formation and closure in inflamed venules of rats. Am J Phys 272:L155–L170. https://doi.org/10.1152/ajplung.1997.272.1.L155
Bates DO, Harper SJ (2002) Regulation of vascular permeability by vascular endothelial growth factors. Vasc Pharmacol 39:225–237
Bazzoni G (2004) Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 84:869–901. https://doi.org/10.1152/physrev.00035.2003
Bekes I, Friedl TWP, Köhler T et al (2016) Does VEGF facilitate local tumor growth and spread into the abdominal cavity by suppressing endothelial cell adhesion, thus increasing vascular peritoneal permeability followed by ascites production in ovarian cancer? Mol Cancer 15:13. https://doi.org/10.1186/s12943-016-0497-3
Broermann A, Winderlich M, Block H et al (2011) Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo. J Exp Med 208:2393–2401. https://doi.org/10.1084/jem.20110525
Caruso RA, Speciale G, Inferrera A et al (2001) Ultrastructural observations on the microvasculature in advanced gastric carcinomas. Histol Histopathol 16:785–792
Cavey M, Rauzi M, Lenne PF, Lecuit T (2008) A two-tiered mechanism for stabilization and immobilization of E-cadherin. Nature 453:751–756. https://doi.org/10.1038/nature06953
Chitaev NA, Troyanovsky SM (1998) Adhesive but not lateral E-cadherin complexes require calcium and catenins for their formation. J Cell Biol 142:837–846. https://doi.org/10.1083/jcb.142.3.837
Curry FRE (2005) Microvascular solute and water transport. Microcirculation 12:17–31
Damert A, Machein M, Breier G et al (1997) Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res 57:3860–3864
Dejana E (2004) Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 5:261–270
Dejana E, Spagnuolo R, Bazzoni G (2001) Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration. Thromb Haemost 86:308–315
Dejana E, Tournier-Lasserve E, Weinstein BM (2009) The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 16:209–221
Dvorak AM, Feng D (2001) The vesiculo-vacuolar organelle (VVO): a new endothelial cell permeability organelle. J Histochem Cytochem 49:419–431
Eliceiri BP, Paul R, Schwartzberg PL et al (1999) Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 4:915–924. https://doi.org/10.1016/S1097-2765(00)80221-X
Esser S, Lampugnani M, Corada M et al (1998) Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci 111(Pt 1):1853–1865
Feng D, Nagy JA, Pyne K et al (1999) Pathways of macromolecular extravasation across microvascular endothelium in response to VPF/VEGF and other vasoactive mediators. Microcirculation 6:23–44
Forstermann U, Sessa WC (2012) Nitric oxide synthases: regulation and function. Eur Heart J 33:829–837
Fukuhra S, Sakurai A, Yamagishi A et al (2006) Vascular endothelial cadherin-mediated cell-cell adhesion regulated by a small GTPase, Rap1. J Biochem Mol Biol 39:132–139. https://doi.org/10.5483/BMBRep.2006.39.2.132
Fukumura D, Gohongi T, Kadambi A et al (2001) Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A 98:2604–2609. https://doi.org/10.1073/pnas.041359198
Furuse M, Tsukita S (2006) Claudins in occluding junctions of humans and flies. Trends Cell Biol 16:181–188
González-Mariscal L, Tapia R, Chamorro D (2008) Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta Biomembr 1778:729–756
Hox V, O’Connell MP, Lyons JJ et al (2015) Diminution of signal transducer and activator of transcription 3 signaling inhibits vascular permeability and anaphylaxis. J Allergy Clin Immunol 138:187–199. https://doi.org/10.1016/j.jaci.2015.11.024
Hudson N, Powner MB, Sarker MH et al (2014) Differential apicobasal VEGF signaling at vascular blood-neural barriers. Dev Cell 30:541–552. https://doi.org/10.1016/j.devcel.2014.06.027
Ivanov D, Philippova M, Antropova J et al (2001) Expression of cell adhesion molecule T-cadherin in the human vasculature. Histochem Cell Biol 115:231–242. https://doi.org/10.1007/s004180100252
Jakobsson L, Kreuger J, Holmborn K et al (2006) Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Dev Cell 10:625–634. https://doi.org/10.1016/j.devcel.2006.03.009
Koch S, Tugues S, Li X et al (2011) Signal transduction by vascular endothelial growth factor receptors. Biochem J 437:169–183. https://doi.org/10.1042/BJ20110301
Kohn S, Nagy JA, Dvorak HF, Dvorak AM (1992) Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels. Lab Investig 67:596–607
Lemmon MA, Schlessinger J (2010) Cell signaling by receptor tyrosine kinases. Cell 141:1117–1134
Majno G, Shea SM, Leventhal M (1969) Endothelial contraction induced by histamine-type mediators: an electron microscopic study. J Cell Biol 42:647–672. https://doi.org/10.1083/jcb.42.3.647
Marshall I (1984) Characterization and distribution of histamine H1- and H2-receptors in precapillary vessels. J Cardiovasc Pharmacol 6:S587–S597. https://doi.org/10.1097/00005344-198406004-00005
Matsumoto T, Bohman S, Dixelius J et al (2005) VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis. EMBO J 24:2342–2353. https://doi.org/10.1038/sj.emboj.7600709
Mehta D, Malik AB (2006) Signaling mechanisms regulating endothelial permeability. Physiol Rev 86:279–367. https://doi.org/10.1152/physrev.00012.2005
Michel CC, Curry F (1999) Microvascular permeability. Physiol Rev 79:703–761
Mukhopadhyay D, Nagy JA, Manseau EJ, Dvorak HF (1998) Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium. Cancer Res 58:1278–1284
Murakami M (2012) Signaling required for blood vessel maintenance: molecular basis and pathological manifestations. Int J Vasc Med 2012:1–15
Nakamura Y, Patrushev N, Inomata H et al (2008) Role of protein tyrosine phosphatase 1B in VEGF signaling and cell-cell adhesions in endothelial cells. Circ Res 102:1182–1191. https://doi.org/10.1161/CIRCRESAHA.107.167080
Navarro P, Ruco L, Dejana E (1998) Differential localization of VE- and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localization. J Cell Biol 140:1475–1484. https://doi.org/10.1083/jcb.140.6.1475
Nelson WJ, Veshnock PJ (1987) Ankyrin binding to (Na++K+)ATPase and implications for the organization of membrane domains in polarized cells. Nature 328:533–536. https://doi.org/10.1038/328533a0
Nilsson I, Bahram F, Li X et al (2010) VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts. EMBO J 29:1377–1388. https://doi.org/10.1038/emboj.2010.30
Orsenigo F, Giampietro C, Ferrari A et al (2012) Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat Commun 3:1208. https://doi.org/10.1038/ncomms2199
Pappenheimer JR (1953) Passage of molecules through capillary walls. Physiol Rev 33:387–423. https://doi.org/10.1152/physrev.1953.33.3.387
Rippe B, Haraldsson B (1994) Transport of macromolecules across microvascular walls: the two-pore theory. Physiol Rev 74:163–219. https://doi.org/10.1152/physrev.1994.74.1.163
Roberts W, Palade G (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108:2369–2379
Sandner P, Wolf K, Bergmaier U et al (1997) Induction of VEGF and VEGF receptor gene expression by hypoxia: divergent regulation in vivo and in vitro. Kidney Int 51:448–453
Senger DR, Galli SJ, Dvorak AM et al (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983–985. https://doi.org/10.1126/science.6823562
Senger DR, Perruzzi CA, Feder J, Dvorak HF (1986) A highly conserved vascular permeability factor secreted by a variety of human. Cancer Res 46:5629–5632
Senger DR, Connolly DT, Van De Water L et al (1990) Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 50:1774–1778
Spanel-Borowski K, Mayerhofer A (1987) Formation and regression of capillary sprouts in corpora lutea of immature superstimulated golden hamsters. Cells Tissues Organs 128:227–235. https://doi.org/10.1159/000146344
Sun Z, Li X, Massena S et al (2012) VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. J Exp Med 209:1363–1377. https://doi.org/10.1084/jem.20111343
Van Itallie CM, Anderson JM (2006) Claudins and epithelial paracellular transport. Annu Rev Physiol 68:403–429. https://doi.org/10.1146/annurev.physiol.68.040104.131404
Vestweber D (2007) Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium. Immunol Rev 218:178–196
Wallez Y, Cand F, Cruzalegui F et al (2007) Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. Oncogene 26:1067–1077. https://doi.org/10.1038/sj.onc.1209855
Weis SM, Cheresh DA (2005) Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437:497–504
Weis S, Shintani S, Weber A et al (2004) Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest 113:885–894. https://doi.org/10.1172/JCI200420702
Wenger RH, Kvietikova I, Rolfs A et al (1997) Hypoxia-inducible factor-1 alpha is regulated at the post-mRNA level. Kidney Int 51:560–563
Wessel F, Winderlich M, Holm M et al (2014) Leukocyte extravasation and vascular permeability are each controlled in vivo by different tyrosine residues of VE-cadherin. Nat Immunol 15:223–230. https://doi.org/10.1038/ni.2824
Xu L, Yoneda J, Herrera C et al (2000) Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases. Int J Oncol 16:445–454
Yano S, Herbst RS, Shinohara H et al (2000) Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Clin Cancer Res 6:957–965
Yap AS, Brieher WM, Gumbiner BM (1997) Molecular and functional analysis of cadherin-based adherens junctions. Annu Rev Cell Dev Biol 13:119–146. https://doi.org/10.1146/annurev.cellbio.13.1.119
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Bekes, I., Wulff, C. (2019). Controlling Vascular Permeability: How Does It Work and What Is the Impact on Normal and Pathological Angiogenesis. In: Marmé, D. (eds) Tumor Angiogenesis. Springer, Cham. https://doi.org/10.1007/978-3-319-31215-6_48-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-31215-6_48-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-31215-6
Online ISBN: 978-3-319-31215-6
eBook Packages: Springer Reference MedicineReference Module Medicine